Aptivus and Hiv infection - a phase IV clinical study of FDA data

Summary:

Hiv infection is reported as a side effect among people who take Aptivus (tipranavir), especially for people who are male, 50-59 old, have been taking the drug for 1 - 2 years also take Norvir, and have Kaposi's sarcoma.

The phase IV clinical study analyzes which people have Hiv infection when taking Aptivus. It is created by eHealthMe based on reports of 1,057 people who have side effects when taking Aptivus from the FDA, and is updated regularly.

What is Aptivus?

Aptivus has active ingredients of tipranavir. eHealthMe is studying from 1,060 Aptivus users. Check the latest studies of Aptivus.

What is Hiv infection?

Hiv infection is found to be associated with 210 drugs and 532 conditions by eHealthMe. Check the latest studies of Hiv infection.

On Jul, 16, 2026

1,057 people reported to have side effects when taking Aptivus.
Among them, 35 people (3.31%) have Hiv infection.

Among these 35 people:

How long have people been on Aptivus when they have Hiv infection? *

What is the gender of people who have Hiv infection when taking Aptivus? *

female: 8.57 %
male: 91.43 %

What is the age of people who have Hiv infection when taking Aptivus? *

What are other drugs people take besides Aptivus? *

What are other side effects people have besides Hiv infection? *

Kaposi's Sarcoma (a tumour caused by human herpes virus): 19 people, 54.29%
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 18 people, 51.43%
Urination - Painful: 18 people, 51.43%
Urinary Tract Infection: 18 people, 51.43%
Lymphoedema (localized fluid retention and tissue swelling): 18 people, 51.43%
Multiple-Drug Resistance: 18 people, 51.43%
Immunodeficiency: 18 people, 51.43%
Laboratory Test Abnormal: 18 people, 51.43%
Rashes (redness): 18 people, 51.43%
Drug Ineffective: 17 people, 48.57%

What are the existing conditions these people have? *

Kaposi's Sarcoma (a tumour caused by human herpes virus): 18 people, 51.43%
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 5 people, 14.29%
Pneumonia: 1 person, 2.86%

* Approximation only. Some reports may have incomplete information.

Do you take Aptivus and have Hiv infection?

- Check whether Hiv infection is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Aptivus:

Aptivus (1,060 reports)

Hiv infection treatments and more:

Hiv infection (176,056 reports)

Browse all side effects of Aptivus:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hiv infection:

Hiv infection (210 drugs)

Browse all the conditions that are associated with Hiv infection:

Hiv infection (532 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on tipranavir (the active ingredients of Aptivus) and Aptivus (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.